Aviara Pharmaceuticals is a privately-held biopharmaceutical company focused on the development of small molecule pharmaceuticals to enhance the effectiveness of cell therapies and treat inflammatory diseases. Aviara is developing a portfolio of small-molecule integrin antagonists against a variety of targets involved in the modulation of cell therapies and inflammatory disease, such as minimal residual disease in cancer, cardiac stem cell transplant, dry eye disease and inflammatory bowel disease.
Company Details
- Employees
- 2
- Founded
- -
- Phone
- (646) 513-3125
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://aviarapharma.com
Aviara Pharmaceuticals Questions
Aviara Pharmaceuticals's helpline number is (646) 513-3125
Aviara Pharmaceuticals's website is http://aviarapharma.com
Aviara Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/aviara-pharmaceuticals
Aviara Pharmaceuticals has
2 employees.
View email and phone details for 2
employees at Aviara Pharmaceuticals.
Aviara Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Aviara Pharmaceuticals's top competitors are
Tandem Diabetes Care,
Viacyte,
Nuvasive,
Cue Health,
Alaunos Therapeutics,
Imprimisrx® - A Harrow Company,
Glycan Therapeutics,
Alvys,
Cusabio Technology Llc,
Immunomet Therapeutics, Inc..
Aviara Pharmaceuticals's support email address is info@aviarapharma.com
Aviara Pharmaceuticals's categories are Pharmaceutical Manufacturing
Aviara Pharmaceuticals's founding year is 2010
